Cellino

🚀 Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure™” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. 📄 Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing

2024 was an amazing year for Cellino, and I'm excited to share highlights from our team here! As we look forward, we are energized to continue building the technology stack that will bring longer, healthier lifespans through the power of personalized cell and tissue replacement therapies. Here’s to an even more exciting 2025 as we continue pushing the boundaries of innovation for patients! 🚀

📢 We’re heading to the 43rd Annual J.P. Morgan Healthcare Conference next week! Our team will be in San Francisco during #JPMWeek, ready to connect with industry leaders, partners, and innovators to discuss how we are shaping the future of personalized regenerative medicine. If you’re attending #JPM2025, we invite you to join us and learn how Cellino is building an ultra-scalable biomanufacturing tech stack to scale the production and accessibility of autologous cell therapies for patients. Join us and meet our team: 🔷 Nabiha Saklayen, Co-Founder & CEO 🔷 Abhijit Kulkarni, Chief Operating Officer 🔷 Chris Gemmiti, Ph.D., SVP of Therapeutics Development  🔷 Rebecca "Becky" Kusko, PhD, Chief of Staff & Head of Strategy 🔷 Luis Alvarez, Lead Advisor, Frontier Therapies We look forward to an exciting week of exploring the challenges and opportunities shaping the future of the industry! See you soon! 🌁 👋 #JPMorganHealthcare #Innovation #Biotech #Healthcare #Biomanufacturing #PersonalizedMedicine #RegenMed #YourCellsYourCure #CellinoBio

🎤 #BiotechShowcase Announcement: Cellino CEO & Co-Founder Nabiha Saklayen will be speaking at Biotech Showcase 2025, taking place in #SanFrancisco from January 13-15, 2025! Nabiha will share how our ultra-scalable #biomanufacturing tech stack is transforming the future of personalized regenerative medicine. She’ll join the "Cell & Gene Therapy: Moving Beyond Discovery and Into the Patient" Workshop 1 (Yosemite A) on Monday, January 13, 2025, from 8:00 - 9:00 AM PT. The panel of featured speakers includes: 🔷 Nabiha Saklayen, CEO & Co-Founder, Cellino 🔷 Paul Bresge, CEO, Ray Therapeutics, Inc. 🔷 Daniel Oliver, CEO, Rejuvenate Bio 🔷 Lexi Rovner, CEO, 64x Bio 🔷 🎗️Ohad Karnieli, Founder & CEO, Adva Biotechnology 🔷 David Ewing Duncan, Journalist, Author, Researcher Join us to explore how Cellino is making personalized, autologous cell therapies more accessible to patients. Learn how our innovations are addressing key challenges in scaling curative therapies. 🗓️ Attending #BiotechShowcase? Request a meeting with our team in advance through the partneringONE portal: https://bit.ly/3DC0Nnu #BiotechShowcase2025 #Biotech #Healthcare #LifeSciences #Innovation #Collaboration #Biomanufacturing #PersonalizedMedicine #RegenMed #CellinoBio #YourCellsYourCure 

📣 We are excited to share that Nabiha Saklayen, our CEO & Co-Founder, will be attending the Longwood Healthcare Leaders #SanFranciscoCEO meeting on January 11-12, 2025! Nabiha will join biopharma CEOs, R&D leaders, top researchers, and life sciences investors for two days of private discussions and networking, focusing on tackling key challenges and driving innovation in #healthcare. Be part of the conversation as Nabiha shares our approach to scaling the production of personalized regenerative medicines and how #AI-driven processes are transforming patient health outcomes! 🚀🔬 👉 Register and learn more here: https://lnkd.in/esNkzCWY #LongwoodHealthcareLeaders #JPM25 #Biotech #LifeSciences #Biomanufacturing #PersonalizedMedicine #RegenMed #CellinoBio #YourCellsYourCure

🎉 As 2024 comes to a close, it has been an extraordinary year of innovation in personalized regenerative medicine. We’ve made incredible progress and are grateful to have you as part of our journey at Cellino. From receiving $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H) to hosting the 2nd Personalized RegenMed Forum (#PRMForum2024), this year reflects our collective commitment to creating a healthier future where personalized therapies are accessible to patients. Take a look at some of this year’s highlighted news and insights: 📌 Cellino Awarded $25M in Funding from the Advanced Research Projects Agency for Health (ARPA-H): https://bit.ly/3BJv2Ii 📌Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progress in Regenerative Medicine: https://bit.ly/41HNjAt 📌 LinkedIn Top Startups 2024: The 10 Companies on the Rise in Boston: https://bit.ly/3BJQRrq  📌 National Academies Emerging Technologies and Innovation in Manufacturing Regenerative Medicine Therapies Proceedings: https://bit.ly/41ITUdZ 👉 Read more news and insights here: https://lnkd.in/gV-vMNGe As our team takes time to rest and recharge, we’ll prepare to return to the office on Thursday, January 2nd. We’re excited to reconnect with all of you soon and to build on this momentum for even greater advancements in 2025! Happy holidays from all of us at Cellino! 🌟🚀 #CellinoBio #OOO #Biotech #Healthcare #LifeSciences #Innovation #Collaboration #Biomanufacturing #PersonalizedMedicine #RegenMed #YourCellsYourCure #HappyHolidays #HappyNewYear

Our CEO & Co-Founder, Nabiha Saklayen, has been selected by the World Economic Forum as a Global Innovator! 🎉 She will join the Global Innovators community, established in 2019 to bring together mission-driven, growth-stage companies addressing key global challenges. As a Global Innovator, Nabiha will share insights on our transformative work to scale personalized regenerative medicines and engage with leaders through the Forum's content-driven initiatives. We’re honored to contribute to shaping a better future and look forward to Nabiha’s impact in this global community at the forefront of disruption and innovation! 🚀 🌐 👉 Learn more about the Global Innovators community here: https://lnkd.in/daE2yJTR #WEF25 #Biotech #BiotechInnovation #Healthcare #LifeSciences #Innovation #Collaboration #Biomanufacturing #PersonalizedMedicine #RegenMed #YourCellsYourCure #Conference

🌟 Danielle Golovin, Ph.D., Senior Biopharma Analyst at BioCentury Inc. recently explored how companies are building reliable products necessary for the scalability of iPSC-based therapies. During the 2024 #BioCenturyGrandRounds panel discussion, Marinna Madrid, PhD, our Co-Founder and Chief Product Officer, highlighted the industry’s shift toward automation, noting that automatized liquid handling is becoming more mainstream, rather than relying on “highly skilled technicians who had just the right amount of coffee that day.” Cellino’s approach leverages AI to aid the quality control process and scale the production of personalized cell and tissue replacement therapies. 📄 Read the full article: https://lnkd.in/gK896giQ   🚀 #Biotech #Innovation #Biomanufacturing #AI #MachineLearning #PersonalizedMedicine #RegenMed #YourCellsYourCure #CellinoBio 

✍️ Exciting news! Nabiha Saklayen, our CEO & Co-Founder, was invited to join the Mass Leads Act Ceremonial Signing & Celebration at the Ragon Institute in #Cambridge, MA. This landmark event, led by Governor Maura Healey, Lt. Governor Kim Driscoll, and Secretary Yvonne Hao, strengthens Massachusetts' position as a global leader in life sciences innovation. During the program, Nabiha shared Cellino’s journey, including our collaboration with the Mass Life Sciences Center internship program, the support we have appreciated from LabCentral and The Engine Accelerator, and the recent funding from Advanced Research Projects Agency for Health (ARPA-H) for NExt-generation Biomanufacturing ULtra-scalable Approach (NEBULA). NEBULA aims to develop affordable and accessible methods for manufacturing personalized cell therapies, addressing chronic diseases like heart disease, Parkinson’s, and diabetes. We’re honored to contribute to this bold initiative, fostering collaboration across the ecosystem to advance #healthequity and drive new breakthroughs in #lifesciences. 🔬 Photography by John Werner Photography #MassLeadsAct #KendallSquare #Biotech #AI #BiotechLeaders #Collaboration #Innovation #PersonalizedMedicine #RegenMed #CellinoBio 

🚀 We’re excited to be in #Riyadh, Saudi Arabia for the CPHI Middle East 2024 conference! Willie T. Reaves, our Head of Public Engagement, will deliver a keynote presentation on December 11, 2024, from 11:15 to 11:45 AM AST. His presentation, “Catalyzing Global Innovation to Extend Healthspan for All,” will explore the urgent need for solutions to help patients live both longer and healthier lives, with a focus on strategies for expanding patient access to potentially curative personalized cell and tissue replacements. We can’t wait to see you there! 🤝 🗓️ Explore the full agenda here: https://lnkd.in/gZ46ygF7 #CPHI #CPHIME #Biotech #AI #MachineLearning #Innovation #Collaboration #FutureOfHealthcare #RegenerativeMedicine #YourCellsYourCure #CellinoBio